DH Stock Analysis: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$0.78
-0.02 (-2.53%)
▼
5d:
+24.16%
30d:
-18.79%
90d:
-28.47%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: DH trading at deep discount. Market pricing in -14.1% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: DH trading at deep discount. Market pricing in -14.1% annual earnings decline, creating value opportunity for patient investors.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $0.78, which is considered oversold relative to its 30-day fair value range of $0.76 to $0.91. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.2) compared to its historical average (6.6). Remarkably, the market is currently pricing in an annual earnings decline of 14.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DH is in a strong downtrend. The price is currently testing key support at $0.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.20 (+182.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DH is in a strong downtrend. The price is currently testing key support at $0.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.20 (+182.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.76 -
$0.91
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 182.2% below Wall St target ($2.20)
Trading Range Analysis
30-Day Trading Range
$0.76 -
$0.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.83
Resistance Level
$1.01
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.21
Wall Street Target
$2.20
(+182.2%)
Revenue Growth (YoY)
-5.5%
Profit Margin
-71.5%
Valuation Discount vs History
-14.1% cheaper
PE vs Historical
4.2 vs 6.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.1%
(market-implied from PE analysis)
1-Year Target
$0.70
(-10%)
2-Year Target
$0.63
(-19%)
3-Year Target
$0.57
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→7)
$0.89
(+14%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 27.0%)
$4.07
(+422%)
Base:
(SPY PE: 4.2, Growth: 27.0%)
$0.79
(+1%)
Bear:
(PE: 3.6, Growth: 27.0%)
$0.67
(-14%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.2 to 6.6
Stabilization Target:
$1.22
(+56.9%)
PE Expansion Potential:
+56.9%
Share & Embed Analysis
Last updated: July 02, 2026 9:43 PM ET
Data refreshes hourly during market hours. Next update: 10:43 PM
Data refreshes hourly during market hours. Next update: 10:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 63 BUY |
